Login / Register

Work

Employment History of Helgi Van De Velde

Sanofi

Head of Hematologic Malignancies Strategies and Late Development

Takeda Oncology

Vice President Oncology Clinical Research

Johnson & Johnson

Director Clinical R and D Oncology

Sanofi Ventures

Head Of Hematologic Malignancies Strategies And Late Development

Schools

Schools Attended by Helgi Van De Velde

  • Saint Luc UCL Univ Hospital Brussels BELGIUM
  • National Cancer Institute, Bethesda, USA
  • Johns Hopkins Oncology Center, Baltimore USA
  • FDA - CDER Oncology Division
  • Sint-Maarteninstituut Aalst
  • Cath Univ Leuven, BELGIUM

Related

Others that have worked at the same companies

Oren Gelman
Sr. Director Global Strategic Marketing at its.jnj.com
Kieran McSherry
Managing Director at its.jnj.com
Vicky Leung-Li
its.jnj.com
Diane Louie
Director, Global Pharmacovigilance and Epidemiology at sanofi.com
Damien Philipot
Co-fondateur at sanofi.com
Liz Nolan
QC Manager at sanofi.com
Nico Vervoort
Director of High Througput Experimentation at prdbe.jnj.com
Erik Mannaert
Sr Scientific Director at prdbe.jnj.com
Trevor Howe
Research fellow at prdbe.jnj.com

Frequently Asked Questions

Helgi Van De Velde is a Head of Hematologic Malignancies Strategies and Late Development at Sanofi located in antwerp, antwerpen, belgium.

Helgi Van De Velde works as a Head of Hematologic Malignancies Strategies and Late Development at Sanofi.

Helgi Van De Velde is located in antwerp, antwerpen, belgium.

Helgi Van De Velde attended Saint Luc UCL Univ Hospital Brussels BELGIUM, National Cancer Institute, Bethesda, USA, Johns Hopkins Oncology Center, Baltimore USA, FDA - CDER Oncology Division, Sint-Maarteninstituut Aalst, Cath Univ Leuven, BELGIUM.

Helgi Van De Velde has worked with colleagues at various companies. You can see some of their coworkers listed above who have worked at the same organizations.

You can send Helgi Van De Velde a message using the contact form on this page, or click "Show Contact Info" to view additional contact details.